Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:39 AM
Ignite Modification Date:
2025-12-25 @ 3:39 AM
NCT ID:
NCT02300402
Eligibility Criteria:
Inclusion Criteria:
* Newly diagnosed hodgkin's lymphoma, diffuse large B-cell lymphoma or follicular lymphoma
* Patients aged over 18
* Initial presentation of bulky disease
Exclusion Criteria:
* Patients with impaired central nervous system
* Patients regularly taking corticosteroids during the 4 weeks preceding the treatment (unless the dose administered is equivalent to ≤20 mg/day prednisone).
* Patients who have undergone major surgery during the 28 days preceding the inclusion
* Patients with low kidney and/or liver function
* Patients with HIV +
* Patients whose life expectancy ≤ 6 months
* Patients with other medical problems or psychological susceptibles interfere with the study,
* Patients under adult supervision.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02300402
Study Brief:
Protocol Section:
NCT02300402